JUST IN: UBS bank maintains its positive recommendation for $NVDA, setting a target price of $245.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
JUST IN: UBS bank maintains its positive recommendation for $NVDA, setting a target price of $245.